Press Release Summary = Animal Replacement Technologies announced today the launch of a new line of synthetic vascular lesion products for medical device developers and surgical educators.
Press Release Body = Animal Replacement Technologies announced today the launch of a new line of synthetic vascular lesion models for medical device designers and surgical educators; chronic total occlusion models. Such models are invaluable to the development of products that treat blockages in the peripheral vascular system since there are currently no other repeatable and reliable models available to engineers and scientists that mimic such pathologies.
Using these models, which are employed in concert with Animal Replacement Technologies\' existing venous and arterial models, will allow developers, researchers, and educators to perform highly compelling benchmarking studies that highlight the performance variations between competitive devices. The company is also developing softcap and hardcap lesions for coronary applications.
Animal Replacement Technologies develops sophisticated synthetic body parts for the medical device, consumer product, and pharmaceutical industries. These models employ replacable muscles, tendons, veins, arteries, and organs, all made from patented materials that mimic the structural, chemical, and mechanical properties of living tissue. Such products are used by medical device manufacturers in design validation testing, by physicians in surgical training, and by armaments manufacturers in ballistics testing.
2022
